Dr. Liem Cong Vu , MD
Physician • Anaheim, CA
111 S Royal Oak Rd
Anaheim, CA 928073622
Phone: 7145883324
Location details and other listingsThis profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
This NPI Is Deactivated in NPPES
NPPES lists this NPI as deactivated as of April 17, 2024; the reason is not published. The records below are historical. They do not show whether Dr. Liem Vu currently practices or holds a license; check the state medical board for current license status.
-
NPI assigned on June 14, 2011; this date does not establish years in practice.
-
Published CMS data list 22 Medicare Part D prescriptions, including refills, in 2020.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020. Published rows only; this is not a quality measure.
-
Published Part D records, 2020:
- Carvedilol — 11 prescription fills, including refills.
- Bumetanide — 11 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 24 in 2014 to 22 in 2020.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2014–2020.
Practice Location & Contact Primary Location
111 S Royal Oak Rd
Anaheim, CA 928073622
What Public CMS Data Show
Physician: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
22 standardized 30-day fills in 2020
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$406 in 2020
The total cost of these prescriptions in 2020, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020.
Open Payments general payments, program year 2020
All general payments: $173.44 across 2 records.
By nature of payment
- Food and Beverage: $173.44 across 2 records.
Reporting-company totals
- Abbott Laboratories: $95.57 across 1 record.
- AstraZeneca Pharmaceuticals LP: $77.87 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2020 (published June 30, 2026).
NPI first issued
2011
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Compared with the same specialty in Anaheim and California
Comparisons are not shown because NPPES lists this NPI as deactivated.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 24 in 2014 and 22 in 2020.
- 2014: 24
- 2016: 13
- 2020: 22
-
30-day fills
30-day fills stayed about the same: 24 in 2014 and 22 in 2020.
- 2014: 24
- 2016: 13
- 2020: 22
-
Part D drug cost
Part D drug cost decreased 90% from $4,207 in 2014 to $406 in 2020.
- 2014: $4,207
- 2016: $5,638
- 2020: $406
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $573.84 in 2019 to $173.44 in 2020.
- 2019: $573.84
- 2020: $173.44
Sources: CMS Medicare Part D Prescribers (2020), CMS Open Payments (2020), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2020 (payments made January 1 – December 31, 2020): fewer than 11 records totaling $173.44.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
Confirm Rx | General | $95.57 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $77.87 |
Source: CMS Open Payments, program year 2020, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2020.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Carvedilol | Carvedilol | 11 | 330 | $28.16 | — |
| Bumetanide | Bumetanide | 11 | 330 | $378.24 | — |
Source: CMS Part D by Provider and Drug, 2020; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 291U00000X
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPPES lists this NPI as deactivated as of April 17, 2024; the reason is not published.
NPI status registered as active in NPPES database
Registered at 111 S ROYAL OAK RD, ANAHEIM, CA 928073622 (Tel: 7145883324)
Registered at 111 S ROYAL OAK RD, ANAHEIM, CA 928073622 (Tel: 7145883324)
Recorded as LIEM VU, M.D.
Clinical Medical Laboratory (license number reported to NPPES: CA A38855)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
111 S Royal Oak Rd
Anaheim, CA 928073622
Phone: 7145883324